iPSC therapy (Cedars-Sinai Medical Center)

N/A

Report date: 2025/01/26 19:28:19

Base Information

Drug NameiPSC therapy (Cedars-Sinai Medical Center)
Drug Alias Nameinduced pluripotent stem cell therapy (Cedars-Sinai Medical Center)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionPeripheral myelin protein 22 modulators
TargetsPeripheral myelin protein 22
Therapy Area/IndicationsCharcot-Marie-Tooth Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCedars-Sinai Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesCedars-Sinai Medical Center
Inactive CompaniesN/A
Active IndicationsCharcot-Marie-Tooth Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A